Atsuko Watanabe
Comptroller/Controller/Auditor bij HanaVax, Inc.
Profiel
Atsuko Watanabe is currently working as an Auditor at HanaVax, Inc. since 2018.
Previously, she worked as a Manager-Business Development at OncoTherapy Science, Inc. in 2019.
Actieve functies van Atsuko Watanabe
| Bedrijven | Functie | Begin |
|---|---|---|
HanaVax, Inc.
 HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Comptroller/Controller/Auditor | 01-11-2018 |
Eerdere bekende functies van Atsuko Watanabe
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
HanaVax, Inc.
HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Health Technology |
